Expression signature of IFN/STAT1 signaling genes predicts poor survival outcome in glioblastoma multiforme in a subtype-specific manner
about
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damageInterferons and their stimulated genes in the tumor microenvironmentARF and p53 coordinate tumor suppression of an oncogenic IFN-β-STAT1-ISG15 signaling axis.The clinical and biological significance of STAT1 in esophageal squamous cell carcinoma.Cancer genomic research at the crossroads: realizing the changing genetic landscape as intratumoral spatial and temporal heterogeneity becomes a confounding factor.Plasma IGFBP-2 levels after postoperative combined radiotherapy and chemotherapy predict prognosis in elderly glioblastoma patients.Stat1 stimulates cap-independent mRNA translation to inhibit cell proliferation and promote survival in response to antitumor drugsHigh expression of N-myc (and STAT) interactor predicts poor prognosis and promotes tumor growth in human glioblastoma.Novel therapeutic targets in the brain tumor microenvironmentIdentification of novel small molecules that inhibit STAT3-dependent transcription and function.Unphosphorylated STAT1 promotes sarcoma development through repressing expression of Fas and bad and conferring apoptotic resistance.GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitors.TCTP is an androgen-regulated gene implicated in prostate cancer.Telomere length influences cancer cell differentiation in vivo.Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs.RIG-I-like receptor LGP2 protects tumor cells from ionizing radiation.MiRNA203 suppresses the expression of protumorigenic STAT1 in glioblastoma to inhibit tumorigenesis.Cancer biomarker discovery: current status and future perspectives.STAT1 and NF-κB Inhibitors Diminish Basal Interferon-Stimulated Gene Expression and Improve the Productive Infection of Oncolytic HSV in MPNST Cells.Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome.Inhibitors of cyclin-dependent kinases as cancer therapeutics.Simian virus 40 large T antigen induces IFN-stimulated genes through ATR kinase.Comprehensive metagenomic analysis of glioblastoma reveals absence of known virus despite antiviral-like type I interferon gene response.Stimulating Innate Immunity to Enhance Radiation Therapy-Induced Tumor Control.MicroRNA203a suppresses glioma tumorigenesis through an ATM-dependent interferon response pathway.Type I interferons modulate methotrexate resistance in gestational trophoblastic neoplasia.MxA expression is associated with tumor-infiltrating lymphocytes and is a prognostic factor in triple-negative breast cancer.Plasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to ResistanceCells with stemness features are generated from in vitro transformed human fibroblasts
P2860
Q24337202-350C236F-ED22-4FF1-8F9E-B6BAD4CF44ECQ33988567-449B4D78-2F2F-4136-830A-322D78AC0743Q34148155-69342A2B-0AC3-4C49-82F1-A0D5401E0C62Q34517533-7D9BE1D6-6114-49AD-AADC-9DE6B79BD0E5Q34537690-44A2D0C1-8FB4-4064-92AF-16A6E7947406Q35137451-8D11915B-8625-4123-A920-8CED18554678Q35567160-EB884A09-9A0F-4322-ADB9-A552EC169B78Q35741574-7316C759-BB37-46D5-A234-72D129E60721Q36071884-5E9F37D0-82AF-4558-88B3-30B00E6F4A1BQ36411459-898F4319-E7B9-4F44-BE98-D4956129D902Q36588875-62A32D6B-81AF-4CFB-A326-55CB9ACDC6B3Q36940404-F721E74A-F66E-49BD-ADFC-3B60B6116E30Q37033465-6086B956-8A6E-4B48-9FB4-E850C40676F6Q37036345-3AC499DB-E584-4BFC-8A4D-655572C71AC6Q37295712-73573955-BD00-43F2-B4AA-368A2DF98AB4Q37543955-A06E9B86-B983-43A5-B58A-B10EB90196C5Q37686230-CE230DF0-D8F2-491D-AC0E-0809C561EB1CQ38187679-D7FA253B-82D0-421C-B804-33B6AE51D4C8Q38793802-55CB6A29-C291-47D6-809A-76959290E0E3Q38867618-4C6CE877-CD76-4F2F-9DAC-204DFB34AABFQ39125016-52318BFB-F56C-4250-937B-7AF31069A7B2Q41846842-0EDF0189-063E-4258-AA59-4103A3C0A101Q42248504-6AD35961-8861-4D04-8124-DA9F5FA98ADEQ46189367-5C9733D2-30D6-4521-BC06-F3B2B255ABF9Q47852882-AB509E46-CD11-4A42-A9A8-AABE8B4DE904Q48123724-EDC39A11-9A49-440F-A65F-F2B7AF0CCDD8Q53122691-85369932-AB60-43A0-AE57-D05E8326B70BQ58729482-0176F3BD-6BE0-4E43-9215-B93BCCE29197Q58740672-8057CEFB-8004-439E-84D0-85F1D713292C
P2860
Expression signature of IFN/STAT1 signaling genes predicts poor survival outcome in glioblastoma multiforme in a subtype-specific manner
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Expression signature of IFN/ST ...... e in a subtype-specific manner
@ast
Expression signature of IFN/ST ...... e in a subtype-specific manner
@en
Expression signature of IFN/ST ...... e in a subtype-specific manner
@nl
type
label
Expression signature of IFN/ST ...... e in a subtype-specific manner
@ast
Expression signature of IFN/ST ...... e in a subtype-specific manner
@en
Expression signature of IFN/ST ...... e in a subtype-specific manner
@nl
prefLabel
Expression signature of IFN/ST ...... e in a subtype-specific manner
@ast
Expression signature of IFN/ST ...... e in a subtype-specific manner
@en
Expression signature of IFN/ST ...... e in a subtype-specific manner
@nl
P2093
P2860
P50
P3181
P1433
P1476
Expression signature of IFN/ST ...... e in a subtype-specific manner
@en
P2093
Christine W Duarte
G Yancey Gillespie
Jacqueline J Harris
Laura Kelly Vaughan
Nikolai N Khodarev
Raymond O McCubrey
Tapan Mehta
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0029653
P407
P577
2012-01-01T00:00:00Z